From: Identifying risks for severity of neurological symptoms in Hungarian West Nile virus patients
Gender and age distribution n (%) | |
---|---|
Male | 42 (63.3) |
Female | 24 (36.4) |
Total | 66 |
Age (average) | 56.74 years |
Age (median) | 60.0 years |
patients below 65 years old | 43 (64.15) |
- patients < 45 years old | 19 (28.79) |
- patients 45-65 years old | 24 (36.4) |
patients over 65 years old | 23 (34.8) |
Time between onset of neurological symptoms and hospital admission (days) | |
average | 6.01 |
median | 4.00 |
Number of Comorbidities n (%) | |
None or 1 illness | 37 (56.1) |
2 or more illnesses | 29 (43.9) |
Relevant medication n (%) | |
None | 59 (89.3) |
Immunsuppressive therapy | 4(6.1) |
Active antitumor therapy | 1 (1.5) |
Steroid therapy | 1 (1.5) |
Data not available (NA) | 1 (1.5) |
General symptoms at presentation n (%) | |
Fever | 61 (92.42) |
Weakness and malaise | 26 (39.4) |
Nausea, vomiting | 26 (39.4) |
Skin rash | 20 (30.3) |
Diarrhea | 7 (10.6) |
Muscle/joint pain | 7 (10.6) |
Abdominal pain | 5 (7.6) |
Coughing, upper respiratory tract symptom | 5 (7.6) |